Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion for smoking cessation after acute coronary syndrome
NCT00689611Phase 3Completed
- Start
- Dec 2005
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 7
01
Overview
Phase 3, randomised, double-blind trial in nicotine dependence comparing Bupropion with Placebo (2 arms). Primary endpoint: Smoking Abstinence at 12 months. Started Dec 2005; status: completed.
02
Drugs
bupropion
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00689611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689611.